Company Filing History:
2 out of 128 
4 out of 832,912 Years Active: 2001-2004
Title: Ronald A Lewis, II: Innovator in Glucose Detection Technology
Introduction
Ronald A Lewis, II is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of glucose detection, holding a total of 7 patents. His innovative methods have advanced the way glucose levels are monitored in urine, providing valuable tools for both medical and veterinary applications.
Latest Patents
Lewis's latest patents focus on threshold glucose detection in urine. One of his inventions outlines methods for glucose detection and quantification in urine. This method involves selecting a test device that includes a matrix impregnated with a chromogenic indicator mixture. The device is designed to promote incidental contact with animal urine, allowing for the reading of a developed indicator color after the device has been wetted. This process ultimately determines the animal's urine glucose concentration. Another patent presents a reagent composition for detecting and quantifying glucose in urine. This composition features a first chromogenic indicator reagent combination that indicates lower glucose concentrations and a second combination for higher concentrations. The first indicator prevents the second from developing color unless a higher glucose concentration is present, along with a scavenger that ensures color development only at a threshold concentration of glucose.
Career Highlights
Throughout his career, Lewis has worked with various companies, including Ralston Purina Company. His experience in these organizations has contributed to his expertise in developing innovative solutions for glucose detection.
Collaborations
Lewis has collaborated with notable professionals in his field, including Michael A Van Lente and Vladimir Evtodienko. These collaborations have likely enriched his work and led to further advancements in glucose detection technology.
Conclusion
Ronald A Lewis, II is a distinguished inventor whose work in glucose detection has made a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical technology.